Persistent endodontic infections—often associated with failed root canal treatments—are commonly caused by bacteria that survive traditional disinfection methods and develop resistance to standard antimicrobial therapies. In this laboratory study, researchers examined whether cannabinoids, including cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinol (THC), could inhibit bacteria frequently found in chronic dental infections. The study focused on Enterococcus […]
Category: CBG
CBD and CBG as Adjunct Support for Trigeminal Neuralgia and Postherpetic Pain (pub. Oct. 2025)
Trigeminal neuralgia and postherpetic neuralgia are forms of neuropathic facial pain that can cause intense, persistent burning or stabbing sensations and are often difficult to manage with conventional medications alone. This clinical case report examined the use of cannabidiol (CBD) and cannabigerol (CBG) as supportive therapies in a patient whose symptoms did not respond adequately […]
Cannabigerol (CBG) Shows Potential for Reducing Neuropathic Pain Through CB2 Receptor Modulation (pub. Oct 2025)
Neuropathic pain occurs when nerves are damaged or irritated, often leading to persistent burning, tingling, or heightened sensitivity to touch. In this study, researchers investigated whether cannabigerol (CBG)—a non-intoxicating cannabinoid found in Cannabis sativa—could reduce pain responses in experimental models of both acute and chronic neuropathic pain. Using rodent models, scientists evaluated behavioral pain responses […]